bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.01.17.633560

Post-movement beta rebound reflects strategic re-aiming during motor adaptation, but not re-aiming accuracy

Abstract

Motor adaptation results from several interacting learning mechanisms, including learning via cognitive strategies and implicit adaptation. While strategy-based and implicit learning can be dissociated at a behavioural level, their underlying systems-level physiology is poorly understood. A neural signal that undergoes pronounced changes during motor adaptation is the post-movement beta-rebound (PMBR). However, it is unclear how these changes relate to the specific learning mechanisms that contribute to motor adaptation. We measured electroencephalography (EEG) while healthy participants (N=27) performed reaching movements towards a target. In most trials, a cursor showed the veridical position of the unseen hand, however, for some reaches, the direction of the cursor was rotated relative to the position of the hand. Participants were informed that, once a rotation occurred, it could persist for a single trial (1x condition), or for two consecutive trial (2x condition). In the 2x condition, participants could therefore redirect the rotated cursor through the target in the second rotated trial by re-aiming, while they had to continue aiming at the target in the 1x condition. We observed a stronger decrease of PMBR following the first rotated reach in the 2x condition, compared to the 1x condition, despite similar kinematics. This corroborates our previous results that PMBR reflects strategic re-aiming (Korka et al., 2023). However, when we collapsed data from the two studies (total N=53), we found that the degree to which the PMBR decreases does not predict re-aiming accuracy. We discuss the role of PMBR in motor adaptation, including implications for clinical disorders.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Will, M., Korka, B., Stenner, M.-P.. 2025-01-18. Post-movement beta rebound reflects strategic re-aiming during motor adaptation, but not re-aiming accuracy. https://doi.org/10.1101/2025.01.17.633560

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗